# Pacira BioSciences (PCRX) — Overview

PCRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pcrx

## Price

Last close $36.33 on Oct 15, 2026. 52-week range $19.16 – $36.40.

## Company profile

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $746.2M |
| Revenue (quarter) | $192.4M |
| Revenue growth (year over year) | 6.24% |
| Gross profit (trailing twelve months) | $591.0M |
| Gross margin | 79.21% |
| Net income (trailing twelve months) | $14.6M |
| Net income (quarter) | $4.7M |
| Net income growth (year over year) | 196.00% |
| Net margin | 1.96% |
| Return on equity | 2.05% |
| EPS (trailing twelve months) | $0.35 |
| Book value per share | $16.87 |
| P/E (trailing twelve months) | 99.1 |
| Price to book | 2.2 |
| Debt to assets | 45.98% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Pacira BioSciences (PCRX) profitable?

Yes. Pacira BioSciences earned $14.6M in net income over the trailing twelve months, a net margin of 1.96%.

### How much revenue does Pacira BioSciences (PCRX) make?

Pacira BioSciences generated $746.2M in revenue over the trailing twelve months, up 6.24% year over year.

### What is PCRX's P/E ratio?

Pacira BioSciences trades at 99.1 times trailing twelve-month earnings, on an EPS of $0.35.

### How do I buy stock in Pacira BioSciences (PCRX)?

PCRX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).